Adam Cuker

Hospital of the University of Pennsylvania — United States

Medicine · Health Sciences

61h-index17.1kcitations377works4.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Venous Thromboembolism Diagnosis and Management(126), Platelet Disorders and Treatments(120), Heparin-Induced Thrombocytopenia and Thrombosis(83), Atrial Fibrillation Management and Outcomes(57), Blood groups and transfusion(55)

Publications376 total

Ianalumab plus Eltrombopag in Immune Thrombocytopenia
New England Journal of Medicine·2025
Foundations of Systems-Based Hematology: Thematic Analysis of Expert Interviews to Guide Curriculums and Promote Growth
Blood Advances·2025Open Access
Primary results from VAYHIT2, a randomized, double-blind, phase 3 trial of ianalumab plus eltrombopag versus placebo plus eltrombopag in patients with primary immune thrombocytopenia (ITP) who failed first-line corticosteroid treatment
Blood·2025Open Access
Impact of Fidanacogene Elaparvovec Gene Therapy on Joint Health in Adults With Haemophilia B: Results From a Phase 3 Study
Haemophilia·2025
Bleeding and Thrombotic Outcomes in Patients With Inflammatory Bowel Disease and Venous Thromboembolism
Blood Advances·2025· 1 citedOpen Access
Multicenter assessment of absolute neutrophil counts (ANC) and white blood cell counts (WBC) in healthy participants with the erythrocyte duffy null phenotype or genotype
Blood·2025
Ianalumab retreatment in adults with primary immune thrombocytopenia (ITP) or warm-antibody autoimmune hemolytic anemia (wAIHA) who benefitted from previous ianalumab treatment: A phase 2 exploratory study
Blood·2025
Raising the bar in maternofetal hematology: Cost-effectiveness of iron deficiency screening in pregnancy across ferritin-based thresholds
Blood·2025
Comparative effectiveness and safety of apixaban vs. rivaroxaban in patients with cirrhosis and portal vein thrombosis: An analysis of real-world data
Blood·2025
Cost-effectiveness of heparin-induced thrombocytopenia (HIT) diagnostic strategies: Rapid PF4/heparin versus ELISA-based antibody testing strategies in the care of hospitalized people with suspected HIT
Blood·2025
Management and outcomes in patients with cryptogenic stroke and weakly positive antiphospholipid antibodies
Blood·2025Open Access
HTRS2025.P1.25 Efficacy and Safety of Fidanacogene Elaparvovec Gene Therapy in US Adults With Hemophilia B: A Subgroup Analysis of the BENEGENE-2 Gene Therapy Trial
Research and Practice in Thrombosis and Haemostasis·2025Open Access
HTRS2025.P2.78 REAL-WORLD UTILIZATION of EPTACOG BETA* in the USA
Research and Practice in Thrombosis and Haemostasis·2025Open Access
HTRS2025.P2.54 Corticosteroid Experience With Fidanacogene Elaparvovec in Adults With Moderately Severe or Severe Hemophilia B: Results From the Phase 3 BENEGENE-2 Gene Therapy Trial
Research and Practice in Thrombosis and Haemostasis·2025Open Access
HTRS2025.P2.94 Drug-Drug Interaction Between Diltiazem with Apixaban and Rivaroxaban Leading to Increased Rates of Major Bleeding
Research and Practice in Thrombosis and Haemostasis·2025Open Access
HTRS2025.P2.90 Evaluation of Patients with Discordant Lupus Anticoagulant testing: A Single Center Retrospective Analysis
Research and Practice in Thrombosis and Haemostasis·2025Open Access
Health-related quality of life in adults with hemophilia B after gene therapy with fidanacogene elaparvovec: results from the BENEGENE-2 trial
Journal of Thrombosis and Haemostasis·2025· 2 cited
Indefinite anticoagulation with reduced-intensity direct oral anticoagulants in patients with splanchnic vein thrombosis. An international practice survey
Blood Coagulation & Fibrinolysis·2025
Emicizumab for preventing intracranial hemorrhage in infants with severe hemophilia A: a cost-effectiveness analysis
Blood Advances·2025· 2 citedOpen Access
Incorporating preprints in systematic reviews: a preliminary study of a novel method for rapid evidence synthesis
Journal of the American Medical Informatics Association·2025
page 1 of 19Next →

Frequent Co-authors

Douglas B. Cines(10), Deborah Siegal(10), Mark Crowther(7), Ignacio Neumann(6), Robby Nieuwlaat(6), Reem A. Mustafa(6), Holger J. Schünemann(5), Wojtek Wiercioch(5), Marc Righini(5), Romina Brignardello‐Petersen(5), Gowthami M. Arepally(4), David García(4), Alfred Ian Lee(4), Elie A. Akl(4), Imad Bou Akl(4), Steven R. Messé(4), Iván D. Flórez(3), Deirdra R. Terrell(3), David J. Kuter(3), Eric Tseng(3)